Back to Global NewsPublished: 11 Mar 2026Download AppJoin TelegramWhy Wellcovorin's FDA Nod May Spark a Rare‑Therapy Rally#Wellcovorin#FDA#Cerebral Folate Deficiency#Orphan Drugs#Biotech Investment#Rare Disease TherapiesDownload AppJoin CommunityShare Article